NCT01761981
- Conditions
- Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
- Locations
-
- Hospital Italiano de Buenos Aires Buenos Aires, Argentina
Clinical trial condition
Hemic and Lymphatic Diseases
Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
21,112 public trials
3,999 recruiting studies
Hemic and Lymphatic Diseases trial results
NCT06967610
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Recruiting
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
NCT07609862
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
NCT07424833
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +33 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Henan Cancer Hospital Zhengzhou, Henan, China
- START Los Angele Los Angeles, California, United States
- START Midwest Grand Rapids, Michigan, United States
NCT07197307
- Conditions
- Aggressive Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL) Grade 3B, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany
- Universitaetsklinikum Aachen Aachen, Germany
- Universitaetsklinikum Augsburg Augsburg, Germany
- Vivantes Netzwerk fuer Gesundheit Berlin, Germany
NCT07571096
- Conditions
- Adnexal Diseases, Cysts, Endocrine System Diseases, +14 more
- Locations
-
- Guangdong Women and Children Hospital Guangzhou, Guangdong, China
NCT06785818
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +17 more
- Locations
-
- Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
- Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
- Novartis Investigative Site Gyeonggi-do, Korea, South Korea
- Novartis Investigative Site Incheon, Korea, South Korea
NCT07652281
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT07024563
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Cardiovascular Diseases, +36 more
- Locations
-
- Research Site Palo Alto, California, United States
- Research Site Aurora, Colorado, United States
- Research Site Beijing, China
- Research Site Shanghai, China
Recruiting
Personalized NK Cell Therapy in CBT
NCT02727803
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States